Pharmaceutical preparations, namely, preparations for treating metabolic disorders, namely, diabetes and obesity; pharmaceutical preparations, namely PTP inhibitors and ligands for treating diabetes and obesity; pharmaceutical preparations, namely PTP1B inhibitors and ligands for treating diabetes and obesity; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases